JP2024521919A5 - - Google Patents
Info
- Publication number
- JP2024521919A5 JP2024521919A5 JP2023574587A JP2023574587A JP2024521919A5 JP 2024521919 A5 JP2024521919 A5 JP 2024521919A5 JP 2023574587 A JP2023574587 A JP 2023574587A JP 2023574587 A JP2023574587 A JP 2023574587A JP 2024521919 A5 JP2024521919 A5 JP 2024521919A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence shown
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163202272P | 2021-06-03 | 2021-06-03 | |
| US63/202,272 | 2021-06-03 | ||
| US202163282588P | 2021-11-23 | 2021-11-23 | |
| US63/282,588 | 2021-11-23 | ||
| PCT/IB2022/055168 WO2022254377A1 (en) | 2021-06-03 | 2022-06-02 | Neodegrader-anti-cd33 antibody conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521919A JP2024521919A (ja) | 2024-06-04 |
| JP2024521919A5 true JP2024521919A5 (https=) | 2025-06-09 |
Family
ID=84323935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574587A Pending JP2024521919A (ja) | 2021-06-03 | 2022-06-02 | ネオデグラダー－抗ｃｄ３３抗体コンジュゲート |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240252671A1 (https=) |
| EP (1) | EP4346910A4 (https=) |
| JP (1) | JP2024521919A (https=) |
| KR (1) | KR20240042598A (https=) |
| AU (1) | AU2022284372A1 (https=) |
| CA (1) | CA3222185A1 (https=) |
| CL (2) | CL2023003605A1 (https=) |
| CO (1) | CO2023016712A2 (https=) |
| IL (1) | IL308812A (https=) |
| MX (1) | MX2023014282A (https=) |
| PE (1) | PE20250159A1 (https=) |
| TW (1) | TW202313022A (https=) |
| WO (1) | WO2022254377A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119212733A (zh) * | 2022-05-18 | 2024-12-27 | 苏州宜联生物医药有限公司 | 包含蛋白降解剂类生物活性化合物的抗体药物偶联物及其制备方法和用途 |
| EP4667463A1 (en) * | 2023-02-15 | 2025-12-24 | CSPC Megalith Biopharmaceutical Co., Ltd. | Domide molecular glue derivative and use thereof |
| WO2024222841A1 (zh) * | 2023-04-27 | 2024-10-31 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| WO2024249235A1 (en) * | 2023-06-01 | 2024-12-05 | Abbvie Inc. | Anti-human cd33 bet degrader antibody-drug conjugates |
| WO2025085489A1 (en) * | 2023-10-17 | 2025-04-24 | Bristol-Myers Squibb Company | Gspt1-degrading compounds, anti-cd33 antibodies and antibody-drug conjugates and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2358697E (pt) * | 2008-10-29 | 2016-02-03 | Celgene Corp | Compostos de isoindolina para utilização no tratamento do cancro |
| PT2822575T (pt) * | 2012-03-03 | 2020-07-02 | Immungene Inc | Moléculas de fusão anticorpos-mutante de interferão modificadas |
| JP2018516950A (ja) * | 2015-06-12 | 2018-06-28 | イミュンジーン, インコーポレイテッドImmunGene, Inc. | がん治療のための集中インターフェロン免疫療法 |
| CN104994263B (zh) * | 2015-06-30 | 2016-12-28 | 广东欧珀移动通信有限公司 | 一种摄像装置及具有该摄像装置的终端 |
| BR112022019532A2 (pt) * | 2020-03-31 | 2022-12-06 | Orum Therapeutics Inc | Conjugados de neodegrader |
-
2022
- 2022-06-02 AU AU2022284372A patent/AU2022284372A1/en active Pending
- 2022-06-02 PE PE2023003198A patent/PE20250159A1/es unknown
- 2022-06-02 EP EP22815474.6A patent/EP4346910A4/en active Pending
- 2022-06-02 JP JP2023574587A patent/JP2024521919A/ja active Pending
- 2022-06-02 MX MX2023014282A patent/MX2023014282A/es unknown
- 2022-06-02 WO PCT/IB2022/055168 patent/WO2022254377A1/en not_active Ceased
- 2022-06-02 KR KR1020247000100A patent/KR20240042598A/ko active Pending
- 2022-06-02 US US18/566,805 patent/US20240252671A1/en active Pending
- 2022-06-02 CA CA3222185A patent/CA3222185A1/en active Pending
- 2022-06-02 IL IL308812A patent/IL308812A/en unknown
- 2022-06-02 TW TW111120735A patent/TW202313022A/zh unknown
-
2023
- 2023-12-01 CL CL2023003605A patent/CL2023003605A1/es unknown
- 2023-12-01 CO CONC2023/0016712A patent/CO2023016712A2/es unknown
-
2026
- 2026-02-10 CL CL2026000399A patent/CL2026000399A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521919A5 (https=) | ||
| US12246196B2 (en) | Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines | |
| JP2024059609A5 (https=) | ||
| JP2024521921A5 (https=) | ||
| JP2022537158A5 (https=) | ||
| TW202400137A (zh) | 喜樹鹼偶聯物 | |
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| JP2023547323A5 (https=) | ||
| WO2023206350A1 (en) | Anti-ccr8 antibodies and uses thereof | |
| JP2013505946A5 (https=) | ||
| JP2022533215A (ja) | 親水性基を含むリンカーを有する抗体薬剤コンジュゲート | |
| JP2020506951A5 (https=) | ||
| TW202400245A (zh) | 抗體藥物偶聯物及其製備方法和用途 | |
| JP2017186337A5 (https=) | ||
| JP7846634B2 (ja) | 抗体－免疫賦活化剤コンジュゲートの新規製造方法 | |
| JP7465347B2 (ja) | 抗ｃ－Ｍｅｔ抗体薬物複合体 | |
| JP2012522513A5 (https=) | ||
| JP2017506234A5 (https=) | ||
| JP2022512401A5 (https=) | ||
| JP2017506630A5 (https=) | ||
| JP2022543231A5 (https=) | ||
| JP2016512223A5 (https=) | ||
| JP2022534297A (ja) | 抗ｂ７－ｈ３抗体 | |
| JP2022510505A5 (https=) | ||
| EP3999118A1 (en) | Antibody-sting agonist conjugates and their use in immunotherapy |